CSS
RPTP

Cubist Systematic Strategies’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Cubist Systematic Strategies’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-46,771
Closed -$420K – 2061
2016
Q3 		$420K Buy
+46,771
New +$333K 0.03% 786
2016
Q1 		– Sell
-15,207
Closed -$79K – 2052
2015
Q4 		$79K Buy
15,207
+13,487
+784% +$78.3K ﹤0.01% 1543
2015
Q3 		$10K Buy
+1,720
New +$21.1K ﹤0.01% 1809
2014
Q4 		– Sell
-1,400
Closed -$13K – 2250
2014
Q3 		$13K Buy
+1,400
New +$14.3K ﹤0.01% 1691

Cubist Systematic Strategies's RPTP Position: Q4 2016 in Review

Cubist Systematic Strategies sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 46,771 shares — an estimated $420K sold.

Cubist Systematic Strategies first reported a position in RPTP in Q3 2014 and held it in 4 quarters. The position peaked at $420K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Cubist Systematic Strategies reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Cubist Systematic Strategies sold 46,771 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $420K.
  • Cubist Systematic Strategies first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2014 and held it in 4 quarters.
  • Cubist Systematic Strategies's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $420K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Cubist Systematic Strategies's 13F filing for Q4 2016, filed 14 Feb 2017.